In China, a continuous R&D pipeline in novel drug discovery, coupled with injectable and oral formulations, is employed in non-alcoholic steatohepatitis (NASH) and Alzheimer's disease, escalating market growth
For most patients, GLP-1 medications are generally safe and well-tolerated, but like any medication, they can have side effects such as nausea, vomiting, diarrhea, or constipation
This multi-system mechanism means dosing must be individualized based on renal function, cardiovascular history, diabetes status, and prior medication responses
86,87 Differing from the effects observed in T2DM, the therapeutic efficacy of dulaglutide for MASLD is not particularly compelling based on current statistics
Be the first one to write one.
Retrieved from